Amgen - IL-33 Asthma/COPD Drug's Unit Acquisition

Amgen - IL-33 Asthma/COPD Drug raised a round of funding on February 01, 2016. Investors include Genentech.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen foc…

Articles about Amgen - IL-33 Asthma/COPD Drug's Unit Acquisition: